دورية أكاديمية

OUTCOME AFTER AZACITIDINE TREATMENT IN PATIENTS WITH HIGH-RISK MYEOLODYSPLASTIC SYNDROME, CHRONIC MYELOMONOCYTIC LEUKEMIA TYPE 2 AND ACUTE MYELOID LEUKEMIA - A SINGLE CENTER EXPERIENCE (PRELIMINARY DATA).

التفاصيل البيبلوغرافية
العنوان: OUTCOME AFTER AZACITIDINE TREATMENT IN PATIENTS WITH HIGH-RISK MYEOLODYSPLASTIC SYNDROME, CHRONIC MYELOMONOCYTIC LEUKEMIA TYPE 2 AND ACUTE MYELOID LEUKEMIA - A SINGLE CENTER EXPERIENCE (PRELIMINARY DATA).
المؤلفون: Varbanova, V., Anastasova-Postadzhiyan, A., Nedeva, A., Nikolov, I., Kindekov, I., Кuyumdzhieva, Y., Petkova, N., Vikentieva, Е., Lubomir, М., Raynov, J.
المصدر: Acta Medica Bulgarica; 2021, Vol. 47 Issue 4, p38-43, 6p
قاعدة البيانات: Complementary Index
الوصف
تدمد:03241750
DOI:10.2478/AMB-2020-0043